Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency

Ophthalmology

Volumn 111, Issue 4, 2004, Pages 775-782

  Reinhard, Thomas ^a,e   Spelsberg, Helga ^b   Henke, Lotte ^c   Kontopoulos, Theodoros ^a   Enczmann, Jürgen ^b   Wernet, Peter ^b   Berschick, Peter ^d   Sundmacher, Rainer ^b   Böhringer, Daniel ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Inst fur Blutgruppenforschung   (Germany)

^d Landeskriminalamt N Rhine Westfalia   (Germany)

^e NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DNA; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CORNEA DISEASE; CORNEA LIMBUS; CORNEA LIMBUS STEM CELL DEFICIENCY; EPITHELIUM CELL; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNE RESPONSE; KAPLAN MEIER METHOD; MALE; PENETRATING KERATOPLASTY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADULT; CELL SURVIVAL; CORNEAL DISEASES; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOGENETICS; IMMUNOSUPPRESSIVE AGENTS; KERATOPLASTY, PENETRATING; LIMBUS CORNEAE; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROGNOSIS; PROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 1842423155     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2003.07.013     Document Type: Article

References (52)

1. Chen J.J., Tseng S.C. Corneal epithelial wound healing in partial limbal deficiency. Invest Ophthalmol Vis Sci. 31:1990;1301-1314.
2. Huang A.J., Tseng S.C. Corneal epithelial wound healing in the absence of limbal epithelium. Invest Ophthalmol Vis Sci. 32:1991;96-105.
3. Kruse F.E. Limbus stem cells and their significance for regeneration of the corneal surface. [in German] Ophthalmologe. 93:1996;633-643.
4. Kruse F.E., Reinhard T. Limbus transplantation for reconstruction of the ocular surface. [in German] Ophthalmologe. 98:2001;818-831.
5. Puangricharern V., Tseng S.C. Cytologic evidence of corneal diseases with limbal stem cell deficiency. Ophthalmology. 102:1995;1476-1485.
6. Hanna C., Irwin E.S. Fate of cells in the corneal graft. Arch Ophthalmol. 68:1962;810-817.
7. Reinhard T., Sundmacher R., Spelsberg H., Althaus C. Homologous penetrating central limbo-keratoplasty (HPCLK) in bilateral limbal stem cell insufficiency. Acta Ophthalmol Scand. 77:1999;663-667.
8. Sundmacher R., Reinhard T. Central corneolimbal transplantation under systemic ciclosporin A cover for severe limbal stem cell insufficiency. Graefes Arch Clin Exp Ophthalmol. 234:(suppl 1):1996;S122-125.
9. Sundmacher R., Reinhard T., Althaus C. Homologous central limbo-keratoplasty in limbus stem cell damage. Retrospective study of 3 years' experience. [in German] Ophthalmologe. 94:1997;897-901.
10. Tsai R.J., Li L.M., Chen J.K. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med. 343:2000;86-93.
11. Kenyon K.R., Tseng S.C. Limbal autograft transplantation for ocular surface disorders. Ophthalmology. 96:1989;709-722., discussion 722-3.
12. Tsai R.J., Sun T.T., Tseng S.C. Comparison of limbal and conjunctival autograft transplantation in corneal surface reconstruction in rabbits. Ophthalmology. 97:1990;446-455.
13. Dua H.S., Azuara-Blanco A. Allo-limbal transplantation in patients with limbal stem cell deficiency. Br J Ophthalmol. 83:1999;414-419.
14. Shimazaki J., Kaido M., Shinozaki N., et al. Evidence of long-term survival of donor-derived cells after limbal allograft transplantation. Invest Ophthalmol Vis Sci. 40:1999;1664-1668.
15. Tsubota K., Satake Y., Kaido M., et al. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med. 340:1999;1697-1703.
16. Solomon A., Ellies P., Anderson D.F., et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology. 109:2002;1159-1166.
17. Herman W.K., Doughman D.J., Lindstrom R.L. Conjunctival autograft transplantation for unilateral ocular surface diseases. Ophthalmology. 90:1983;1121-1126.
18. Duke-Elder S., Leigh A. Diseases of the outer eye. Part 2. Cornea and sclera. Duke-Elder S. System of Ophthalmology. Vol. 8. 1965;648-651 Henry Kimpton, London.
19. Kuckelkorn R., Redbrake C., Schrage N.F., Reim M. Keratoplasty with 11-12 mm diameter for management of severely chemical-burned eyes. [in German] Ophthalmologe. 90:1993;683-687.
20. European Eye Bank Association Directory. 8th ed. Amsterdam: 12th Meeting of the European Eye Bank Association; 2000:1-12
21. Wernet P., Kögler G., Enczmann J., et al. Rapid method for successful HLA class I and II typing from cadaveric blood for direct matching in cornea transplantation. Graefes Arch Clin Exp Ophthalmol. 236:1998;507-512.
22. Hoffmann F. Suture technique for perforating keratoplasty. [in German] Klin Monatsbl Augenheilkd. 169:1976;584-590.
23. Hill J.C. Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy. Ophthalmology. 101:1994;128-133.
24. Reinhard T., Sundmacher R., Heering P. Systemic ciclosporin A in high-risk keratoplasties. Graefes Arch Clin Exp Ophthalmol. 234:(suppl 1):1996;S115-121.
25. Reis A., Reinhard T., Voiculescu A., et al. Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients a prospective, randomized clinical trial. Br J Ophthalmol. 83:1999;1268-1271.
26. Reinhard T., Reis A., Böhringer D., et al. Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients 3 years' results of a randomized prospective clinical trial. Graefes Arch Clin Exp Ophthalmol. 239:2001;367-372.
27. Alldredge O.C., Krachmer J.H. Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment. Arch Ophthalmol. 99:1981;599-604.
28. Sundmacher R. Allograft rejection after keratoplasty. [in German] Klin Monatsbl Augenheilkd. 171:1977;705-722.
29. Daya S.M., Bell R.W., Habib N.E., et al. Clinical and pathologic findings in human keratolimbal allograft rejection. Cornea. 19:2000;443-450.
30. Budowle B., Sprecher C.J. Concordance study on population database samples using the PowerPlex 16 kit and AmpFlSTR Profiler Plus kit and AmpFlSTR COfiler kit. J Forensic Sci. 46:2001;637-641.
31. Ludes B., Clisson I. Short Tandem Repeat loci analysis in forensic casework. Anthropol Anz. 58:2000;23-27.
32. Moretti T.R., Baumstark A.L., Defenbaugh D.A., et al. Validation of short tandem repeats (STRs) for forensic usage performance testing of fluorescent multiplex STR systems and analysis of authentic and simulated forensic samples. J Forensic Sci. 46:2001;647-660.
33. GeneScan [computer program]. Version 3.1. Foster City, CA: Applied Biosystems
34. SPSS Windows NT [computer program]. Version 4.0. Chicago: SPSS Inc
35. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
36. Reinhard T., Sundmacher R., Godehardt E., Heering P. Preventive systemic cyclosporine A after keratoplasty at increased risk for immune reactions as the only elevated risk factor. [in German] Ophthalmologe. 94:1997;496-500.
37. Opelz G., Mytilineos J., Scherer S., et al. Analysis of HLA-DR matching in DNA-typed cadaver kidney transplants. Transplantation. 55:1993;782-785.
38. Streilein W. Unraveling immune privilege. Science. 270:(5239):1995;1158- 1159.
39. Newsome D.A., Takasugi M., Kenyon K., et al. Human corneal cells in vitro morphology and histocompatibility antigens of pure cell populations. Invest Ophthalmol Vis Sci. 13:1974;23-32.
40. Jager M.J. Corneal Langerhans cells and ocular immunology. Reg Immunol. 4:1992;186-195.
41. Hamrah P., Zhang Q., Liu Y., Dana M.R. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest Ophthalmol Vis Sci. 43:2002;639-646.
42. Liu Y., Hamrah P., Zhang Q., et al. Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Med. 195:2002;259-268.
43. Collaborative Corneal Transplantation Studies Research Group. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol. 110:1992;1392-1403.
44. Hopkins K.A., Maguire M.G., Fink N.E., Bias W.B. Reproducibility of HLA A, B, and DR typing using peripheral blood samples results of retyping in the collaborative corneal transplantation studies. Hum Immunol. 33:1992;122-128.
45. Reinhard T, Böhringer D, Enczmann J, et al. Improvement of graft prognosis after penetrating normal-risk keratoplasty by HLA-matching. Eye. In press
46. Völker-Dieben H.J., Claas F.H.J., Schreuder G.M.T., et al. Beneficial effect of HLA-DR matching on the survival of corneal allografts. Transplantation. 70:2000;640-648.
47. Goulmy E., Pool J., van Lochem E., Völker-Dieben H. The role of human minor histocompatibility antigens in graft failure a mini-review. Eye. 9:1995;180-184.
48. Niederkorn J.Y. Mechanisms of corneal graft rejection. The sixth annual Thygeson lecture, presented at the Ocular Microbiology and Immunology Groups meeting, October 21, 2000. Cornea. 20:2001;675-679.
49. Reis A., Megahed H., Reinhard T., et al. Coadministration of the new macrolide immunosuppressant RAD and mycophenolate mofetil in experimental corneal transplantation. Transplantation. 70:2000;1397-1401.
50. Reis A., Megahed H., Reinhard T., et al. Synergism of RAD and cyclosporin A in prevention of acute rat corneal allograft rejection. Cornea. 86:2002;81-84.
51. Reinhard T., Reis A., Mayweg S., et al. Topical FK506 in inflammatory corneal and conjunctival diseases. A pilot study. [in German] Klin Monatsbl Augenheilkd. 219:2002;125-131.
52. Henderson T.R., Coster D.J., Williams K.A. The long term outcome of limbal allografts the search for surviving cells. Br J Ophthalmol. 85:2001;604-609.